Company profile
Anison Therapeutics company profile
Anison Therapeutics develops a technology designed for critical disease-causing components of the human papillomavirus. It identifies a compound from an ancient medicinal plant that completely eliminates HPV through a molecular mechanism that has received a broad international patent.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2021-01-01
Headquarters
- Headquarters
- Turku, Southwest Finland, Finland
- Country code
- FI
- Continent
- Europe